Summit Therapeutics
SMMT
#1215
Rank
โ‚ฌ16.47 B
Marketcap
21,25ย โ‚ฌ
Share price
2.99%
Change (1 day)
-3.00%
Change (1 year)

Market capitalization of Summit Therapeutics (SMMT)

Market cap: โ‚ฌ16.47 Billion

As of April 2026 Summit Therapeutics has a market cap of โ‚ฌ16.47 Billion. This makes Summit Therapeutics the world's 1215th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Summit Therapeutics from 2015 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ16.47 B43.33%
2025โ‚ฌ11.49 B-10.92%
2024โ‚ฌ12.90 B679.89%
2023โ‚ฌ1.65 B107.45%
2022โ‚ฌ0.79 B243.67%
2021โ‚ฌ0.23 B-26.16%
2020โ‚ฌ0.31 B227.6%
2019โ‚ฌ95.94 M480.13%
2018โ‚ฌ16.53 M-88%
2017โ‚ฌ0.13 B37.73%
2016โ‚ฌ0.10 B-22.38%
2015โ‚ฌ0.12 B

End of Day market cap according to different sources

On Apr 17th, 2026 the market cap of Summit Therapeutics was reported to be:

โ‚ฌ16.48 Billion
by Nasdaq info icon info icon
โ‚ฌ16.47 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sarepta Therapeutics
SRPT
โ‚ฌ1.91 B-88.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
โ‚ฌ0.18 B-98.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
โ‚ฌ0.25 B-98.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
โ‚ฌ5.20 B-68.38%๐Ÿ‡บ๐Ÿ‡ธ USA